Third Arc Bio
Develops novel multifunctional antibodies for oncology and immunology & inflammation indications
$52MSeries A+
Role not disclosedAV
AbbVie Ventures
Activity from announced rounds
Activity in this selectionjefferies-family-office-9ab84067
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $52M 1 disclosed · full round size, not this investor’s share